Carfilzomib and Belatacept for Desensitization
Clinical trial NCT05017545 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05017545
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2027-02-28
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.